Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 150.00
-3.00 (-1.96%)
May 12, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 6.5 billion as of May 12, 2026. Its market cap has increased by 9.49% in one year.
Market Cap
6.50B
Enterprise Value
2.58B
Revenue
5.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
150.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 6.50B, a decrease of -78.97%. That is a compound annual growth rate of -41.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 6.63B | 15.04% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.77B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.53B |
| ADR120S | 7.31B |
| CellSource | 7.18B |
| Chiome Bioscience | 7.02B |